• Halliburton (NYSE:HAL) has launched the Next-Generation Energy Accelerators Joint Lab, known as NEX Lab, in partnership with Singapore’s A*STAR and the Economic Development Board.
• The joint lab will focus on developing and commercializing advanced energy technologies, including well completion solutions and low carbon applications.
• The initiative strengthens Halliburton’s research and development footprint in Asia and supports the growth of local technical talent.

For investors watching the oilfield services space, NEX Lab adds a new element to the Halliburton story. The company’s core business is centered on well construction and completion, and this partnership connects directly to that focus while incorporating emerging low carbon applications that many energy companies are exploring.

Looking ahead, this can be treated as one more data point on how Halliburton is positioning its technology pipeline and regional presence. The key question is how the lab’s work will translate into commercial offerings and whether it will help the company reach new customers or contract types in Asia over time.

Stay updated on the most important news stories for Halliburton by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Halliburton.

Quick Assessment

• ✅ Price vs Analyst Target: At US$34.16, the share price sits below the US$35.58 analyst target range midpoint.
• ✅ Simply Wall St Valuation: Simply Wall St flags the shares as undervalued, trading 54.8% below its estimated fair value.
• ✅ Recent Momentum: The 30 day return of 0.22% is slightly positive, suggesting flat to modest recent momentum.

Check out Simply Wall St's in depth valuation analysis for Halliburton.

Key Considerations

• 📊 NEX Lab connects Halliburton’s core well completion offering with new low carbon applications, which could broaden how the business is positioned with customers in Asia.
• 📊 It may be useful to monitor how management discusses NEX Lab in future updates, including any referenced contract wins, commercialization milestones or capital spend tied to the partnership.
• ⚠️ Profit margins of 5.8% are below last year’s 10.9%, so investors may want to see whether new R&D initiatives contribute to profitability or weigh on it.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Halliburton analysis.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.